Bessemer Group’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
Bessemer Group's SWTX Position: Q2 2025 in Review
Bessemer Group sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 182,357 shares — an estimated $8.05M sold.
Bessemer Group first reported a position in SWTX in Q1 2020 and held it in 21 quarters. The position peaked at $24.2M in Q4 2020. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Bessemer Group reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Bessemer Group sold 182,357 SpringWorks Therapeutics shares in Q2 2025, an estimated $8.05M.
- Bessemer Group first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 21 quarters.
- Bessemer Group's SpringWorks Therapeutics position peaked at $24.2M in Q4 2020.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Bessemer Group's 13F filing for Q2 2025, filed 1 Aug 2025.